This method is efficient for protein-protein or protein-peptide fusions at the N-or C-termini. It enables the generation of defined and completely labeled antibody conjugates with one fusion partner ...
Researchers from Anaveon AG and affiliated organizations presented the discovery and preclinical characterization of ANV-700, a novel proximity-activated cytokine (PAC) compound designed to ...